Pioglitazone for the Treatment of Bipolar Depression
Status:
Terminated
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
The primary objective is to test the hypothesis that adjunctive pioglitazone is more
effective than placebo for the relief of acute depressive symptoms resulting from bipolar
disorder. The secondary objectives are to determine potential moderators and mediators of
antidepressant efficacy.
Phase:
Phase 4
Details
Lead Sponsor:
University Hospitals Cleveland Medical Center
Collaborator:
The Depressive and Bipolar Disorder Alternative Treatment Foundation